Allergy Rx for Pediatrics: 66.7% of denials overturned
In 9 California IMR decisions from 2019 to 2025, reviewers overturned 6 (66.7%). In the last five years: 100.0% of 2. 6 were medical-necessity disputes, 3 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 1 | 100.0% |
| 2025 | 1 | 100.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 4 | 100.0% | 66.7% |
| Urgent or emergencyThe findings mention urgency. | 4 | 100.0% | 66.7% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient’s parent has requested authorization and coverage for Palforzia. Palforzia is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. The U.S. Food and Drug Administration (FDA) approves the use of Palforzia for patients over age four with …”
“The physician reviewer found that : The patient’s parent has requested authorization and coverage for Palforzia including the initial dose escalation phase, up-dosing phase, and maintenance phases. This patient has a documented allergy to peanut. The patient’s provider has recommended treatment with Palforzia, which is a means of prevention of anaphylaxis upon accidental exposure to peanut. Oral immunotherapy as a …”
“Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for prednisolone sodium phosphate oral dissolving tablets (Orapred-ODT). It is critical for this for this patient’s family and caregivers to have immediate access to emergency medications, such as epinephrine autoinjectors in case of allergic reactions that occur outside the presence of medical supervision. In addition, adjunctive medications …”
And one the reviewer upheld
“Nature of Statutory Criteria/Case Summary: An enrollee’s parent has requested authorization and coverage for sublingual immunotherapy and/or food tolerance induction. This patient presents with food allergies and eczema. His parent has requested treatment in a tolerance induction program. Currently, the American Academy of Allergy Asthma and Immunology (AAAAI) does not recommend tolerance induction as a standard of care treatment for …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Allergy Rx denials for Pediatrics overturned?
In 9 California IMR decisions from 2019 to 2025, reviewers overturned 6 (66.7%). In the last five years: 100.0% of 2. 6 were medical-necessity disputes, 3 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.